Cargando…

Driving restrictions after implantable cardioverter defibrillator implantation: an evidence-based approach

AIMS: Little evidence is available regarding restrictions from driving following implantable cardioverter defibrillator (ICD) implantation or following first appropriate or inappropriate shock. The purpose of the current analysis was to provide evidence for driving restrictions based on real-world i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thijssen, Joep, Borleffs, C. Jan Willem, van Rees, Johannes B., de Bie, Mihály K., van der Velde, Enno T., van Erven, Lieselot, Bax, Jeroen J., Cannegieter, Suzanne C., Schalij, Martin J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2011
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3205477/ https://www.ncbi.nlm.nih.gov/pubmed/21646229 http://dx.doi.org/10.1093/eurheartj/ehr161

Ejemplares similares

Improvements in 25 Years of Implantable Cardioverter Defibrillator Therapy
por: van Welsenes, G. H., et al.
Publicado: (2010)

Should mechanical dyssynchrony be assessed in patients with implantable cardioverter-defibrillators?
por: Boogers, Mark J., et al.
Publicado: (2010)

One-Year Mortality in Patients Undergoing an Implantable Cardioverter Defibrillator or Cardiac Resynchronization Therapy Pulse Generator Replacement: Identifying Patients at Risk
por: Feijen, Michelle, et al.
Publicado: (2023)

The development of a decision aid for shared decision making in the Dutch implantable cardioverter defibrillator patient population: A novel approach to patient education
por: Yilmaz, Dilek, et al.
Publicado: (2022)

Influence of Diabetes on Left Ventricular Systolic and Diastolic Function and on Long-Term Outcome After Cardiac Resynchronization Therapy
por: Höke, Ulas, et al.
Publicado: (2013)

Implantable cardioverter-defibrillators /
Publicado: (1994)

Driving restrictions in patients with implantable cardioverter defibrillators and pacemakers
por: Watanabe, Eiichi, et al.
Publicado: (2017)

Implantation of Implantable Cardioverter Defibrillators in Kazakhstan
por: Begisbayev, Temirkhan, et al.
Publicado: (2022)

Evaluation of the Impact of a Chronic Total Coronary Occlusion on Ventricular Arrhythmias and Long‐Term Mortality in Patients With Ischemic Cardiomyopathy and an Implantable Cardioverter‐Defibrillator (the eCTOpy‐in‐ICD Study)
por: van Dongen, Ivo M., et al.
Publicado: (2018)

Remote monitoring of implantable cardioverter defibrillators: Patient experiences and preferences for follow‐up
por: Timmermans, Ivy, et al.
Publicado: (2019)

Deactivation of implantable cardioverter-defibrillators
por: Wan, Darryl, et al.
Publicado: (2021)

The subcutaneous implantable cardioverter-defibrillator should be considered for all patients with an implantable cardioverter-defibrillator indication
por: Tan, Jian Liang, et al.
Publicado: (2022)

Dutch Outcome in Implantable Cardioverter‐Defibrillator Therapy: Implantable Cardioverter‐Defibrillator–Related Complications in a Contemporary Primary Prevention Cohort
por: van Barreveld, Marit, et al.
Publicado: (2021)

Subcutaneous implantable cardioverter-defibrillator placement in a patient with a preexisting transvenous implantable cardioverter-defibrillator
por: Jazayeri, Mohammad-Ali, et al.
Publicado: (2017)

Relation of multicenter automatic defibrillator implantation trial implantable cardioverter-defibrillator score with long-term cardiovascular events in patients with implantable cardioverter-defibrillator
por: Uslu, Abdulkadir, et al.
Publicado: (2018)

A sustained ventricular tachycardia overlooked by subcutaneous implantable cardioverter-defibrillator but recognized by co-implanted transvenous implantable cardioverter defibrillator
por: Goto, Kentaro, et al.
Publicado: (2020)

Remote Monitoring of Implantable Cardioverter Defibrillator
por: Reynolds, Dwight W, et al.
Publicado: (2006)

The Subcutaneous Implantable Cardioverter-Defibrillator: Not For All
por: Nair, Krishnakumar, et al.
Publicado: (2014)

Programming implantable cardioverter/defibrillators and outcomes
por: Horlbeck, Fritz W., et al.
Publicado: (2015)

Implantable cardioverter–defibrillator in hypertrophic cardiomyopathy
por: Sanchez, Diego Jimenez, et al.
Publicado: (2018)

Defibrillation testing during implantation of the subcutaneous implantable cardioverter-defibrillator: a necessary standard or becoming redundant?
por: van der Stuijt, W., et al.
Publicado: (2020)

Intrapericardial Implantation of an Implantable Cardioverter-Defibrillator in a Child
por: Seong, Yong Won, et al.
Publicado: (2011)

Characteristics of Cardiac Memory in Patients with Implanted Cardioverter-defibrillators: The Cardiac Memory with Implantable Cardioverter-defibrillator (CAMI) Study
por: Haq, Kazi T., et al.
Publicado: (2021)

Optimizing patient selection for primary prevention implantable cardioverter-defibrillator implantation: utilizing multimodal machine learning to assess risk of implantable cardioverter-defibrillator non-benefit
por: Kolk, Maarten Z H, et al.
Publicado: (2023)

Psychosocial impact of implantable cardioverter defibrillators (ICD) in young adults with Tetralogy of Fallot
por: Opić, Petra, et al.
Publicado: (2012)

Evolution of extravascular implantable cardioverter-defibrillator therapy for ventricular arrhythmias
por: Römers, Hans, et al.
Publicado: (2022)

Impairment of Quality of Life in Patients with Implanted Subcutaneous Cardioverter Defibrillator (S-ICD) Compared to Implanted Transvenous Cardioverter Defibrillator Therapy
por: Thienel, Manuela, et al.
Publicado: (2022)

Driving restrictions for Dutch patients with an implantable cardioverter defibrillator: Compliance and associated factors
por: Jongejan, N., et al.
Publicado: (2017)

Defibrillation Testing of the Implantable Cardioverter Defibrillator: When, How, and by Whom?
por: Pires, Luis A
Publicado: (2007)

Predictors of Elevated Defibrillation Threshold with the Subcutaneous Implantable Cardioverter-defibrillator
por: Do, Khuyen, et al.
Publicado: (2017)

Implantable cardioverter defibrillators at the end of life: future perspectives on clinical practice
por: Stoevelaar, R., et al.
Publicado: (2020)

Azygos Vein Lead Implantation For High Defibrillation Thresholds In Implantable Cardioverter Defibrillator Placement
por: Kommuri, Naga VA, et al.
Publicado: (2010)

Induced atrial fibrillation during defibrillation test on implantation of subcutaneous implantable cardioverter defibrillator
por: Kim, Ki-Hun, et al.
Publicado: (2020)

Implantation of a subcutaneous implantable cardioverter-defibrillator in a patient with epicardial defibrillation patches
por: Yoshizawa, Reisuke, et al.
Publicado: (2021)

Implantable Cardioverter-Defibrillator Implantation in a Patient with Atrial Standstill
por: Park, So Ra, et al.
Publicado: (2009)

Quality of Life in Patients with Implantable Cardioverter Defibrillators
por: Francis, Johnson, et al.
Publicado: (2006)

Perioperative Management of Patients with Implantable Cardioverter Defibrillators
por: Donnelly, Patrick, et al.
Publicado: (2007)

Electrical Storms in Patients with an Implantable Cardioverter Defibrillator
por: Song, Pil Sang, et al.
Publicado: (2011)

The use of implantable cardioverter defibrillators in pediatric patients
por: Campagnucci, V, et al.
Publicado: (2013)

The first cardioverter defibrillator implanted in Central Africa
por: Cabral, Tantchou Tchoumi Jacques, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_agn306es783n0i7rj0rhuhoh2m